Lonza Group AG
![Lonza Group AG](https://api.admiralmarkets.com/trade_icons/bright-128/LONN.png)
Затворен
536 0.49
Преглед
Промяна на цената на акция
24 ч
Минимум
534.2
Максимум
546
Приходи | 244M |
---|---|
Продажби | -582M 3.1B |
P/E Средно за сектора | 26.67 |
EPS | 4.61 |
Марж на печалбата | 6.705 |
Пазарна капитализация | -144M 40B |
---|---|
Предишно отваряне | 535.51 |
Предишно затваряне | 536 |
Настроения в новините
By Acuity
50%
50%
Lonza Group AG Графика
Свързани новини
Lonza Group AG Прогноза
Настроение
By Acuity
Настроения в новините
Neutral
Волатилност
Под средното
Обем новини (RCV)
Над средното
Финанси
Оперативни разходи
Печалба преди облагане с данъци
Продажби
Разходи за продажби
Брутна печалба от продажби
Разходи за лихви по дълг
EBITDA
Оперативна печалба
$
Относно Lonza Group AG
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life science industries. The Company's offerings include custom development and manufacturing of drugs and drug delivery systems, as well as development of anti-microbial solutions for commercial applications. The Company divides its activities into two segments: Pharma&Biotech and Specialty Ingredients. The Pharma&Biotech comprises the Company's Biologics, Small-Molecule, and Consumables and Research Tools businesses. The segment includes mammalian, microbial, chemical, bioconjugates, cell and gene therapy technology platforms. The Specialty Ingredients segment focuses on anti-microbial applications within Consumer Health division, which covers hygiene, nutrition and personal care products, as well as preservatives, capsules and food supplements, among others, and Consumer & Resources Protection division, which includes coatings and composites, and agro ingredients.